Dwight Winstead
Amministratore Delegato presso Cardinal Health 101, Inc.
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Michael A. Lynch | M | 63 |
Cardinal Health, Inc. /Clinical & Medical Products Division/
 Cardinal Health, Inc. /Clinical & Medical Products Division/ Medical SpecialtiesHealth Technology Cardinal Health, Inc. manufactures medical and clinical equipment. It offers alaris, fluid suction, patient prep, glove, and pyxis products. It provides carefusion, surgical instrument repair, interventional specialties, and pharmacy management services. The company is headquartered in Dublin, OH. | - |
| Tracy Gould | F | - |
Cardinal Health 101, Inc.
 Cardinal Health 101, Inc. Miscellaneous Commercial ServicesCommercial Services Cardinal Health 101, Inc. provides pharmacy management and information services for hospitals in the United States. It provides inventory control products such as its web-based supply line database that is used by healthcare facilities. The company is headquartered in Houston, TX. | - |
| Karen Orso | F | - |
Cardinal Health 101, Inc.
Cardinal Health 101, Inc. Miscellaneous Commercial ServicesCommercial Services Cardinal Health 101, Inc. provides pharmacy management and information services for hospitals in the United States. It provides inventory control products such as its web-based supply line database that is used by healthcare facilities. The company is headquartered in Houston, TX. | - |
| David L. Schlotterback | M | - |
Cardinal Health, Inc. /Clinical & Medical Products Division/
Cardinal Health, Inc. /Clinical & Medical Products Division/ Medical SpecialtiesHealth Technology Cardinal Health, Inc. manufactures medical and clinical equipment. It offers alaris, fluid suction, patient prep, glove, and pyxis products. It provides carefusion, surgical instrument repair, interventional specialties, and pharmacy management services. The company is headquartered in Dublin, OH. | - |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Michelle Burris | F | 58 |
Sonus Pharmaceuticals, Inc.
 Sonus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sonus Pharmaceuticals, Inc. engaged in the development of drugs for the treatment of cancer and related therapies. Its primary product TOCOSOL Paclitaxel, was an injectable paclitaxel emulsion for nonsmall cell lung cancer, ovarian cancer and bladder cancer. Sonus Pharmaceuticals was incorporated in 1991 and was headquartered in Bothell, WA.
OncoGenex Pharmaceuticals, Inc.
 OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoGenex Pharmaceuticals, Inc. is a biopharmaceutical company, which engages develops and commercializes new cancer therapies that address treatment resistance in cancer patients. Its product include custirsen, apatorsen, and OGX-225. The company was founded by Martin E. Gleave and Scott Daniel Cormack in October 1991 and is headquartered in Bothell, WA. | 9 anni |
| Cameron Lawrence | M | 44 |
OncoGenex Pharmaceuticals, Inc.
OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoGenex Pharmaceuticals, Inc. is a biopharmaceutical company, which engages develops and commercializes new cancer therapies that address treatment resistance in cancer patients. Its product include custirsen, apatorsen, and OGX-225. The company was founded by Martin E. Gleave and Scott Daniel Cormack in October 1991 and is headquartered in Bothell, WA. | 4 anni |
| Jack Goldstein | M | 77 |
OncoGenex Pharmaceuticals, Inc.
OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoGenex Pharmaceuticals, Inc. is a biopharmaceutical company, which engages develops and commercializes new cancer therapies that address treatment resistance in cancer patients. Its product include custirsen, apatorsen, and OGX-225. The company was founded by Martin E. Gleave and Scott Daniel Cormack in October 1991 and is headquartered in Bothell, WA. | 7 anni |
| Michelle Griffin | F | 58 |
Sonus Pharmaceuticals, Inc.
Sonus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sonus Pharmaceuticals, Inc. engaged in the development of drugs for the treatment of cancer and related therapies. Its primary product TOCOSOL Paclitaxel, was an injectable paclitaxel emulsion for nonsmall cell lung cancer, ovarian cancer and bladder cancer. Sonus Pharmaceuticals was incorporated in 1991 and was headquartered in Bothell, WA.
OncoGenex Pharmaceuticals, Inc.
OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoGenex Pharmaceuticals, Inc. is a biopharmaceutical company, which engages develops and commercializes new cancer therapies that address treatment resistance in cancer patients. Its product include custirsen, apatorsen, and OGX-225. The company was founded by Martin E. Gleave and Scott Daniel Cormack in October 1991 and is headquartered in Bothell, WA. | 9 anni |
| Joan B. Stafslien | F | 59 | 6 anni | |
| Michael O'Halleran | M | 73 | 6 anni | |
| David L. Schlotterbeck | M | 77 | 2 anni | |
| C. Thomas Smith | M | 86 |
VHA, Inc.
 VHA, Inc. Miscellaneous Commercial ServicesCommercial Services VHA, Inc. operates a health care network of not-for-profit hospitals. It provides medical practice management services. The firm offers networking and education services for health care workers. The company was founded in 1977 and is headquartered in Irving, TX. | 16 anni |
| Kieran Gallahue | M | 60 | 4 anni | |
| Curt Nonomaque | M | 66 |
VHA, Inc.
VHA, Inc. Miscellaneous Commercial ServicesCommercial Services VHA, Inc. operates a health care network of not-for-profit hospitals. It provides medical practice management services. The firm offers networking and education services for health care workers. The company was founded in 1977 and is headquartered in Irving, TX. | 29 anni |
| Steven Quay | M | 73 |
Sonus Pharmaceuticals, Inc.
Sonus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sonus Pharmaceuticals, Inc. engaged in the development of drugs for the treatment of cancer and related therapies. Its primary product TOCOSOL Paclitaxel, was an injectable paclitaxel emulsion for nonsmall cell lung cancer, ovarian cancer and bladder cancer. Sonus Pharmaceuticals was incorporated in 1991 and was headquartered in Bothell, WA. | 8 anni |
| Michael Martino | M | 68 |
Sonus Pharmaceuticals, Inc.
Sonus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sonus Pharmaceuticals, Inc. engaged in the development of drugs for the treatment of cancer and related therapies. Its primary product TOCOSOL Paclitaxel, was an injectable paclitaxel emulsion for nonsmall cell lung cancer, ovarian cancer and bladder cancer. Sonus Pharmaceuticals was incorporated in 1991 and was headquartered in Bothell, WA.
OncoGenex Pharmaceuticals, Inc.
OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoGenex Pharmaceuticals, Inc. is a biopharmaceutical company, which engages develops and commercializes new cancer therapies that address treatment resistance in cancer patients. Its product include custirsen, apatorsen, and OGX-225. The company was founded by Martin E. Gleave and Scott Daniel Cormack in October 1991 and is headquartered in Bothell, WA. | 12 anni |
| Edward Miller | M | 81 | 6 anni | |
| Robert Chapel | M | - |
VHA, Inc.
VHA, Inc. Miscellaneous Commercial ServicesCommercial Services VHA, Inc. operates a health care network of not-for-profit hospitals. It provides medical practice management services. The firm offers networking and education services for health care workers. The company was founded in 1977 and is headquartered in Irving, TX. | 19 anni |
| Gregory Lucier | M | 59 | 6 anni | |
| Neil James Clendeninn | M | 74 |
OncoGenex Pharmaceuticals, Inc.
OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoGenex Pharmaceuticals, Inc. is a biopharmaceutical company, which engages develops and commercializes new cancer therapies that address treatment resistance in cancer patients. Its product include custirsen, apatorsen, and OGX-225. The company was founded by Martin E. Gleave and Scott Daniel Cormack in October 1991 and is headquartered in Bothell, WA. | - |
| Stephen Charles Anderson | M | 61 |
OncoGenex Pharmaceuticals, Inc.
OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoGenex Pharmaceuticals, Inc. is a biopharmaceutical company, which engages develops and commercializes new cancer therapies that address treatment resistance in cancer patients. Its product include custirsen, apatorsen, and OGX-225. The company was founded by Martin E. Gleave and Scott Daniel Cormack in October 1991 and is headquartered in Bothell, WA. | 2 anni |
| Vivek Jain | M | 52 | 5 anni | |
| Philip L. Francis | M | 77 | 6 anni | |
| H. Parker | F | 68 |
OncoGenex Pharmaceuticals, Inc.
OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoGenex Pharmaceuticals, Inc. is a biopharmaceutical company, which engages develops and commercializes new cancer therapies that address treatment resistance in cancer patients. Its product include custirsen, apatorsen, and OGX-225. The company was founded by Martin E. Gleave and Scott Daniel Cormack in October 1991 and is headquartered in Bothell, WA. | - |
| Patricia S. Stewart | M | - |
OncoGenex Pharmaceuticals, Inc.
OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoGenex Pharmaceuticals, Inc. is a biopharmaceutical company, which engages develops and commercializes new cancer therapies that address treatment resistance in cancer patients. Its product include custirsen, apatorsen, and OGX-225. The company was founded by Martin E. Gleave and Scott Daniel Cormack in October 1991 and is headquartered in Bothell, WA. | - |
| Jacqueline Kosecoff | M | 74 | 6 anni | |
| Robert Paul Wayman | M | 78 | 6 anni | |
| Robert Friel | M | 68 | 6 anni | |
| Martin Mattingly | M | 66 |
OncoGenex Pharmaceuticals, Inc.
OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoGenex Pharmaceuticals, Inc. is a biopharmaceutical company, which engages develops and commercializes new cancer therapies that address treatment resistance in cancer patients. Its product include custirsen, apatorsen, and OGX-225. The company was founded by Martin E. Gleave and Scott Daniel Cormack in October 1991 and is headquartered in Bothell, WA. | 7 anni |
| Thomas Leonard | M | 56 | - | |
| J. Losh | M | 78 | 6 anni | |
| James Paloyan | M | - | 6 anni | |
| Benjamin Goux | M | 51 |
Sonus Pharmaceuticals, Inc.
Sonus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sonus Pharmaceuticals, Inc. engaged in the development of drugs for the treatment of cancer and related therapies. Its primary product TOCOSOL Paclitaxel, was an injectable paclitaxel emulsion for nonsmall cell lung cancer, ovarian cancer and bladder cancer. Sonus Pharmaceuticals was incorporated in 1991 and was headquartered in Bothell, WA. | 3 anni |
| Richard Daifuku | M | 71 |
Sonus Pharmaceuticals, Inc.
Sonus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sonus Pharmaceuticals, Inc. engaged in the development of drugs for the treatment of cancer and related therapies. Its primary product TOCOSOL Paclitaxel, was an injectable paclitaxel emulsion for nonsmall cell lung cancer, ovarian cancer and bladder cancer. Sonus Pharmaceuticals was incorporated in 1991 and was headquartered in Bothell, WA. | 4 anni |
| Nathaniel Sisitsky | M | 50 | 6 anni | |
| Douglas Armitage | M | - |
VHA, Inc.
VHA, Inc. Miscellaneous Commercial ServicesCommercial Services VHA, Inc. operates a health care network of not-for-profit hospitals. It provides medical practice management services. The firm offers networking and education services for health care workers. The company was founded in 1977 and is headquartered in Irving, TX. | - |
| Elaine Waller | M | 72 |
Sonus Pharmaceuticals, Inc.
Sonus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sonus Pharmaceuticals, Inc. engaged in the development of drugs for the treatment of cancer and related therapies. Its primary product TOCOSOL Paclitaxel, was an injectable paclitaxel emulsion for nonsmall cell lung cancer, ovarian cancer and bladder cancer. Sonus Pharmaceuticals was incorporated in 1991 and was headquartered in Bothell, WA. | 5 anni |
| Todd M. Austin | M | 62 | 4 anni | |
| Mark Low | M | - |
Sonus Pharmaceuticals, Inc.
Sonus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sonus Pharmaceuticals, Inc. engaged in the development of drugs for the treatment of cancer and related therapies. Its primary product TOCOSOL Paclitaxel, was an injectable paclitaxel emulsion for nonsmall cell lung cancer, ovarian cancer and bladder cancer. Sonus Pharmaceuticals was incorporated in 1991 and was headquartered in Bothell, WA. | 3 anni |
| Anthony Lopez | M | - | 2 anni | |
| Mary G. Bolton | M | - |
Sonus Pharmaceuticals, Inc.
Sonus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sonus Pharmaceuticals, Inc. engaged in the development of drugs for the treatment of cancer and related therapies. Its primary product TOCOSOL Paclitaxel, was an injectable paclitaxel emulsion for nonsmall cell lung cancer, ovarian cancer and bladder cancer. Sonus Pharmaceuticals was incorporated in 1991 and was headquartered in Bothell, WA. | 1 anni |
| Carlos Nunez | M | - | - | |
| Cynthia Hare | F | - |
VHA, Inc.
VHA, Inc. Miscellaneous Commercial ServicesCommercial Services VHA, Inc. operates a health care network of not-for-profit hospitals. It provides medical practice management services. The firm offers networking and education services for health care workers. The company was founded in 1977 and is headquartered in Irving, TX. | - |
| Don Abbey | M | 57 | 7 anni | |
| Rosemary Curran | F | - |
VHA, Inc.
VHA, Inc. Miscellaneous Commercial ServicesCommercial Services VHA, Inc. operates a health care network of not-for-profit hospitals. It provides medical practice management services. The firm offers networking and education services for health care workers. The company was founded in 1977 and is headquartered in Irving, TX. | - |
| Robert E. Ivy | M | 90 |
Sonus Pharmaceuticals, Inc.
Sonus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sonus Pharmaceuticals, Inc. engaged in the development of drugs for the treatment of cancer and related therapies. Its primary product TOCOSOL Paclitaxel, was an injectable paclitaxel emulsion for nonsmall cell lung cancer, ovarian cancer and bladder cancer. Sonus Pharmaceuticals was incorporated in 1991 and was headquartered in Bothell, WA. | 9 anni |
| Daniel P. Bourque | M | - |
VHA, Inc.
VHA, Inc. Miscellaneous Commercial ServicesCommercial Services VHA, Inc. operates a health care network of not-for-profit hospitals. It provides medical practice management services. The firm offers networking and education services for health care workers. The company was founded in 1977 and is headquartered in Irving, TX. | - |
| Jonathan Wesley Porter | M | 54 | 3 anni | |
| Ed Borkowski | M | 64 | 1 anni | |
| Michael B. Stewart | M | - |
Sonus Pharmaceuticals, Inc.
Sonus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sonus Pharmaceuticals, Inc. engaged in the development of drugs for the treatment of cancer and related therapies. Its primary product TOCOSOL Paclitaxel, was an injectable paclitaxel emulsion for nonsmall cell lung cancer, ovarian cancer and bladder cancer. Sonus Pharmaceuticals was incorporated in 1991 and was headquartered in Bothell, WA. | - |
| Alan Fuhrman | M | 67 |
Sonus Pharmaceuticals, Inc.
Sonus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sonus Pharmaceuticals, Inc. engaged in the development of drugs for the treatment of cancer and related therapies. Its primary product TOCOSOL Paclitaxel, was an injectable paclitaxel emulsion for nonsmall cell lung cancer, ovarian cancer and bladder cancer. Sonus Pharmaceuticals was incorporated in 1991 and was headquartered in Bothell, WA. | 4 anni |
| Craig Steven Eudy | M | 58 |
Sonus Pharmaceuticals, Inc.
Sonus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sonus Pharmaceuticals, Inc. engaged in the development of drugs for the treatment of cancer and related therapies. Its primary product TOCOSOL Paclitaxel, was an injectable paclitaxel emulsion for nonsmall cell lung cancer, ovarian cancer and bladder cancer. Sonus Pharmaceuticals was incorporated in 1991 and was headquartered in Bothell, WA. | 6 anni |
| Cathy Cooney | F | 72 | 2 anni | |
| Jean Maschal | F | 72 | 5 anni | |
| Carol Zilm | F | 69 | 1 anni | |
| Jonathan Wygant | M | 53 | 7 anni | |
| George Dunbar | M | 77 |
Sonus Pharmaceuticals, Inc.
Sonus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sonus Pharmaceuticals, Inc. engaged in the development of drugs for the treatment of cancer and related therapies. Its primary product TOCOSOL Paclitaxel, was an injectable paclitaxel emulsion for nonsmall cell lung cancer, ovarian cancer and bladder cancer. Sonus Pharmaceuticals was incorporated in 1991 and was headquartered in Bothell, WA. | 11 anni |
| Carol A. Cox | F | - | 2 anni | |
| Gregory Sessler | M | 71 |
Sonus Pharmaceuticals, Inc.
Sonus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sonus Pharmaceuticals, Inc. engaged in the development of drugs for the treatment of cancer and related therapies. Its primary product TOCOSOL Paclitaxel, was an injectable paclitaxel emulsion for nonsmall cell lung cancer, ovarian cancer and bladder cancer. Sonus Pharmaceuticals was incorporated in 1991 and was headquartered in Bothell, WA. | 5 anni |
| Cindy Jacobs | M | 66 |
OncoGenex Pharmaceuticals, Inc.
OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoGenex Pharmaceuticals, Inc. is a biopharmaceutical company, which engages develops and commercializes new cancer therapies that address treatment resistance in cancer patients. Its product include custirsen, apatorsen, and OGX-225. The company was founded by Martin E. Gleave and Scott Daniel Cormack in October 1991 and is headquartered in Bothell, WA. | - |
| Richard J. Klein | M | 61 |
Sonus Pharmaceuticals, Inc.
Sonus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sonus Pharmaceuticals, Inc. engaged in the development of drugs for the treatment of cancer and related therapies. Its primary product TOCOSOL Paclitaxel, was an injectable paclitaxel emulsion for nonsmall cell lung cancer, ovarian cancer and bladder cancer. Sonus Pharmaceuticals was incorporated in 1991 and was headquartered in Bothell, WA. | 8 anni |
| David E. Wormuth | M | 78 |
Sonus Pharmaceuticals, Inc.
Sonus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sonus Pharmaceuticals, Inc. engaged in the development of drugs for the treatment of cancer and related therapies. Its primary product TOCOSOL Paclitaxel, was an injectable paclitaxel emulsion for nonsmall cell lung cancer, ovarian cancer and bladder cancer. Sonus Pharmaceuticals was incorporated in 1991 and was headquartered in Bothell, WA. | 5 anni |
| Pat R. Brady | M | - |
OncoGenex Pharmaceuticals, Inc.
OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoGenex Pharmaceuticals, Inc. is a biopharmaceutical company, which engages develops and commercializes new cancer therapies that address treatment resistance in cancer patients. Its product include custirsen, apatorsen, and OGX-225. The company was founded by Martin E. Gleave and Scott Daniel Cormack in October 1991 and is headquartered in Bothell, WA. | 1 anni |
| Robert Reed | M | 72 |
VHA, Inc.
VHA, Inc. Miscellaneous Commercial ServicesCommercial Services VHA, Inc. operates a health care network of not-for-profit hospitals. It provides medical practice management services. The firm offers networking and education services for health care workers. The company was founded in 1977 and is headquartered in Irving, TX. | 2 anni |
| Kenneth Bailey | M | 55 |
OncoGenex Pharmaceuticals, Inc.
OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoGenex Pharmaceuticals, Inc. is a biopharmaceutical company, which engages develops and commercializes new cancer therapies that address treatment resistance in cancer patients. Its product include custirsen, apatorsen, and OGX-225. The company was founded by Martin E. Gleave and Scott Daniel Cormack in October 1991 and is headquartered in Bothell, WA. | 2 anni |
| Monica Krieger | M | 75 |
OncoGenex Pharmaceuticals, Inc.
OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoGenex Pharmaceuticals, Inc. is a biopharmaceutical company, which engages develops and commercializes new cancer therapies that address treatment resistance in cancer patients. Its product include custirsen, apatorsen, and OGX-225. The company was founded by Martin E. Gleave and Scott Daniel Cormack in October 1991 and is headquartered in Bothell, WA. | - |
| Mark Hazeltine | M | 50 | 5 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 67 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Dwight Winstead
- Contatti personali
